CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
6599.6
0.44%
Market Trading Hours* (UTC) Opens on Monday at 00:00

Mon - Fri: 00:00 - 02:30 03:30 - 06:00

  • Summary
  • Historical Data
Trading сonditions
Spread 41.8
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.011247 %
Charges from full value of position ($-2.14)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011247%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.010976 %
Charges from full value of position ($-2.09)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.010976%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5.00%
Stock exchange Japan
Commission on trade 0%

Key Stats
Prev. Close 6570.8
Open 6687.6
1-Year Change -25.38%
Day's Range 6599.6 - 6732
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 26, 2024 6599.6 -34.2 -0.52% 6633.8 6743.4 6594.8
Jul 25, 2024 6575.0 30.0 0.46% 6545.0 6625.7 6535.0
Jul 24, 2024 6512.9 -31.0 -0.47% 6543.9 6608.7 6488.2
Jul 23, 2024 6553.9 45.8 0.70% 6508.1 6579.8 6508.1
Jul 22, 2024 6542.9 -39.8 -0.60% 6582.7 6582.8 6479.0
Jul 19, 2024 6587.8 -78.8 -1.18% 6666.6 6671.5 6537.9
Jul 18, 2024 6674.4 120.6 1.84% 6553.8 6767.0 6547.9
Jul 17, 2024 6599.8 60.8 0.93% 6539.0 6653.5 6539.0
Jul 16, 2024 6533.9 -182.5 -2.72% 6716.4 6749.3 6532.0
Jul 12, 2024 6928.9 75.7 1.10% 6853.2 6938.2 6820.3
Jul 11, 2024 6904.8 223.1 3.34% 6681.7 6904.8 6680.7
Jul 10, 2024 6595.8 12.3 0.19% 6583.5 6615.4 6537.0
Jul 9, 2024 6595.7 110.7 1.71% 6485.0 6626.6 6477.1
Jul 8, 2024 6493.0 35.9 0.56% 6457.1 6518.4 6452.1
Jul 5, 2024 6445.1 65.8 1.03% 6379.3 6452.0 6357.1
Jul 4, 2024 6355.5 -17.9 -0.28% 6373.4 6391.3 6309.6
Jul 3, 2024 6533.8 -27.0 -0.41% 6560.8 6624.7 6477.0
Jul 2, 2024 6604.0 -40.6 -0.61% 6644.6 6644.6 6505.9
Jul 1, 2024 6569.6 0.0 0.00% 6569.6 6659.5 6569.6
Jun 28, 2024 6576.8 -12.0 -0.18% 6588.8 6655.6 6556.9

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Eisai Co., Ltd. Company profile

About Eisai Co., Ltd

Eisai Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Eisai Co., Ltd revenues increased 13% to Y565.33B. Net income applicable to common stockholders increased 34% to Y60.36B. Revenues reflect Other Business segment increase from Y43.85B to Y92.54B, Pharmaceutical Business segment increase of 3% to Y449.48B, China segment increase of 25% to Y83.14B, America segment increase of 13% to Y125.19B, Asia/Latin America segment increase of 10% to Y38.04B.

Equity composition

FY'99-02 WAS & FY'04 DWAS were estimated. FY'03 DWAS was adjusted to reflect reported DEPS. FY'04-06 1Q&3Q WAS & O/S were estimated. 12/05 DPS estimated. FY'08 Q1&Q3 DWAS were estimated. FY'08 Q1&Q3 WAS = O/S. FY'11 Q3 DWAS estimated.

Industry: Pharmaceuticals (NEC)

エーザイ本館
小石川4-6-10
BUNKYO-KU
TOKYO-TO 112-8088
JP

People also watch

Gold

2,387.21 Price
+0.940% 1D Chg, %
Long position overnight fee -0.0190%
Short position overnight fee 0.0108%
Overnight fee time 21:00 (UTC)
Spread 0.60

US100

19,029.00 Price
+1.080% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

67,979.90 Price
+3.920% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.60 Price
+0.450% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading